Stage 4 Signet Ring Cell Carcinoma Life Expectancy

Stage 4 signet ring cell carcinoma is a serious diagnosis. The cancer is named for how its cells look under a microscope: each one holds a pocket of mucus that pushes the nucleus to the side, like the stone on a ring. For most people, the expected time is counted in months to a few years rather than decades. Those averages hide a wide range, and where the cancer began and which treatments a person can have shift the picture considerably.

Typical Survival Numbers for Stage 4 Disease

Doctors often describe outlook as median survival, the point by which half of people with the same cancer have died and half are still living. In large US records of colorectal signet ring cell cancer, about 4 to 5 in 100 people diagnosed at stage 4 were alive 5 years later.¹ Across all stages of colorectal signet ring cancer, typical survival was 16 months, which shows how many of these cancers are found late.² For stomach signet ring cancer at all stages, typical survival was about 22 months.³

Those colorectal and stomach figures come from different groups of people, with different stages at diagnosis and different treatments, so they shouldn’t be lined up as a ranking of which cancer is worse. The all-stage stomach figure and the stage 4 figure also answer different questions. One mixes early and late disease; the other covers only people whose cancer has already spread. If your cancer started somewhere not mentioned here, such as the esophagus or appendix, ask for numbers for that site rather than borrowing the stomach or colon ones.

Treatment makes a visible difference. In people with stage 4 stomach signet ring cancer, typical survival was about 13 months with surgery plus chemotherapy.⁴ It was about 7 months with only one of those treatments.⁵

A median is not a personal prediction. Half of people live longer than it, and some live much longer. The figures also come from people diagnosed years ago, before newer drugs, so someone starting treatment now may do somewhat differently. Health, age and how the cancer responds to treatment move a person above or below the middle.

A 5-year figure says how many people reach that point, not how the others fared before it. A low 5-year number fits with many people living a year or two, so ask for a typical survival figure alongside it.

When you talk with your oncologist, ask what typical survival looks like for your cancer site and treatment plan, and what would move that estimate up or down. Ask, too, how the team will judge whether treatment is working.

How Survival Differs by Where the Cancer Started

In colon and rectal cancer, the signet ring type carried a 42 to 57% higher risk of death than the common type at the same stage.⁶ About 8 in 10 colorectal signet ring cancers are found at stage 3 or 4,⁷ so many people meet the diagnosis already facing spread, and that pulls the overall picture down. Colon and rectal cancers are grouped in these figures, so ask your team whether your tumor’s exact location changes the surgical options.

Most people with signet ring cancer of the appendix already have spread when diagnosed, about 7 in 10.⁸ Typical survival with distant spread was about 19 months in national records.⁹ Appendix cancer often causes no clear symptoms until it spreads, and when it does it can look like appendicitis. Some people learn the diagnosis only after the appendix is removed for what seemed to be an ordinary infection and the pathology report reveals the cancer. Because it tends to spread across the lining of the abdomen, further scans and sometimes a look inside the abdomen are used to plan next steps.

In stomach cancer, the signet ring type does better than other types when caught early but worse once it has spread.¹⁰ In esophageal cancer, the signet ring type shortens survival at every stage, for example 22 versus 30 months at stage 3.¹¹ The esophagus and the junction where it meets the stomach are sometimes treated with similar drug regimens, so ask which category your tumor falls into.

A pathology report may mention a “signet ring component.” Some tumors are mostly signet ring cells and others contain a small share. Even a small share has been linked to poorer outcomes in colorectal and appendix cancer, so ask the pathologist or oncologist what percentage was found.

Why This Cancer Spreads the Way It Does

Almost all signet ring cancers have lost a protein that holds neighboring cells together.¹² Without it, the cells scatter rather than forming a single lump.¹³ They tend to spread over the thin lining of the abdomen and to the ovaries, rather than to the liver or lungs.¹⁴ About 3 in 4 colorectal signet ring cancers that spread went to the peritoneum or ovaries.¹⁵

Cells that hold together form a lump a scan can measure. Cells that have lost their glue can move through the wall of an organ like ink through paper. That’s why the wall of the stomach can thicken and stiffen without a clear mass, and why the cancer can be present before it is easy to see.

Tiny scattered deposits on the lining may not show on CT scans. Fluid can build up in the belly, causing swelling and fullness. Bloating, poor appetite and bowel blockage are common results, which is why survival depends so heavily on controlling disease in the abdomen.

The ovaries sit in the abdomen, so cells shed from a bowel or stomach tumor can land on them and grow. In women, a mass on the ovary can be the first sign that a stomach or colon cancer has spread, and it can look like a primary ovarian cancer until pathology says otherwise. Some doctors discuss removing the ovaries in certain women, but that decision depends on the stage and the other treatment planned.

The tumor’s surroundings play a part too. In the stomach, these tumors are surrounded by tissue that weakens killer immune cells.¹⁶ That helps the cancer resist treatment as it advances.¹⁷

How Well Chemotherapy and Immunotherapy Work

In advanced stomach signet ring cancer treated with chemotherapy, typical survival was 5.6 months versus 9.4 months for other types.¹⁸ Chemotherapy is still the backbone of treatment, but expectations should be tempered. One proposed explanation is that signet ring cells tend to divide more slowly than many other cancer cells, and chemotherapy drugs work best on fast-dividing ones. Researchers are still working out the full picture, so that isn’t settled.

Chemotherapy is given in repeating cycles with rest periods between them, so a course is a long series of treatments, not a single event. Combinations of two or three drugs are common in stomach and colorectal cancer, and the mix depends on your health and the tumor’s tests. Some drugs are given by infusion in a clinic and others as pills at home. Scans every two to three months check whether the cancer is shrinking or stable, and treatment can be changed if it stops working. Side effects such as fatigue and nausea can often be managed so you can keep going.

With PD-1 immunotherapy in advanced stomach cancer, tumors shrank in about 3 in 10 signet ring patients versus about 5 in 10 others.¹⁹ Typical survival was 15.3 months for signet ring patients compared with 17.4 months for others.²⁰

It isn’t offered to everyone. Whether it is added depends on tumor tests and the type of cancer, and tests such as mismatch repair status help show whether it is likely to help, which is why testing matters before treatment begins. Its side effects differ from chemotherapy’s because they come from an overactive immune system, so new diarrhea, rash or breathlessness should be reported promptly.

When Surgery Is an Option

Removing the stomach and then giving chemotherapy gave longer survival than either alone in stage 4 stomach signet ring cancer.²¹ Surgery in stage 4 disease is usually offered only when the cancer is limited enough that the visible disease can be removed and the person is fit enough to recover. Many people aren’t candidates, and hearing that surgery isn’t an option is common and doesn’t mean care has stopped. Doctors often start with chemotherapy and then rescan to see whether surgery has become possible.

Cytoreductive surgery with HIPEC removes visible tumor in the abdomen and then bathes it with heated chemotherapy. The operation can last many hours, and the surgeon removes deposits from the surface of organs and the abdominal lining. The heated drug is then circulated through the abdomen for a set period before the incision is closed, so it reaches tiny deposits that can’t be seen. Recovery usually means a hospital stay of a week or more and weeks to months before feeling back to normal.

For appendix signet ring cancer, typical survival after debulking surgery with heated chemotherapy was 32 months compared with about 91 months for other appendix cancers.²² Getting all visible tumor out was one of the strongest signs of longer survival.²³ For colorectal signet ring cancer spread to the abdominal lining, typical survival after this surgery was about 14 months, and cancer returned in about 7 in 10.²⁴ A surgeon will often discuss how extensive your disease is before suggesting it.

A newer option sprays chemotherapy as a mist in the abdomen. In stomach cancer patients, mostly signet ring, survival was about 19 months and 1 in 7 became fit for full surgery.²⁵

Useful questions for a surgeon: Can all visible tumor be removed? How many of these operations does your center perform each year? What recovery time and complication risks apply to me? Would a specialist peritoneal center offer a second opinion?

Factors That Shape an Individual Outlook

In stomach signet ring cancer, deeper tumors, more lymph nodes involved and not having surgery all predicted shorter survival.²⁶ Pathology reports describe how far the tumor has grown into or through the organ wall, and deeper growth generally means higher risk. Lymph node involvement is reported as the number of nodes with cancer out of the number examined, and a higher number points to a worse outlook. In appendix signet ring cancer, 5-year survival fell from about 45% to under 8% when the tumor had grown through the organ wall.²⁷

Signet ring cancer tends to strike younger adults.²⁸ Younger people are often assumed to do better, but here symptoms can be missed or put down to other causes, so diagnosis comes later. In colon signet ring cancer, people 35 or younger fared worse, often because their cancer was further along.²⁹

Tumor markers can change the options. Stomach signet ring cancers are less often HER2-positive, a marker that would unlock a targeted drug.³⁰ But about 95% of advanced stomach signet ring cancers carry Claudin18.2, a target for newer drugs.³¹ Ask whether your tumor was tested for HER2, Claudin18.2 and mismatch repair. A positive result can open extra treatment options, and the testing uses tissue already taken at biopsy.

Overall health counts as well. Doctors often rate how well you can carry out daily activities, and people who are up and about most of the day tend to tolerate treatment better and live longer. Weight loss and poor appetite are also taken into account, so keeping up nutrition is part of treatment. Other conditions, such as heart or kidney disease, can limit which drugs are safe.

Family Risk and Genetic Testing

An inherited change in the CDH1 gene causes about 30% of a family syndrome of stomach signet ring cancer.³² Carriers have about an 80% lifetime risk of this stomach cancer and 60% for lobular breast cancer.³³ Because early disease is hard to see on scopes, carriers are usually advised to have the stomach removed in advance.³⁴

Most signet ring cancers happen by chance, so one diagnosis in a family doesn’t automatically mean relatives are at risk. The inherited form is more likely when a cancer appears at a young age or in several relatives. Those are the times to raise genetic testing. A genetic counselor can arrange a blood or saliva test, and a positive result lets children and siblings decide on testing themselves.

A relative who carries the change has a high lifetime risk but hasn’t necessarily developed cancer. Carriers are usually offered regular stomach scoping while deciding about preventive surgery, though early disease can still be missed. Women who carry the change are also offered breast screening.

Comfort Care and Living With Advanced Disease

Palliative care is a medical specialty focused on comfort and quality of life, provided by a team that works alongside your cancer doctors. It isn’t only end-of-life care and can run alongside chemotherapy. Hospice is different: it is for people who have stopped cancer treatment and are near the end of life. Some people choose to forgo cancer treatment, and outcomes vary widely between individuals. You can ask your oncologist for a referral at any point after diagnosis.

The team manages pain, nausea, appetite and fluid build-up. Draining belly fluid can bring quick relief. Discussing goals and wishes early, while energy is good, makes it easier to match care to what matters to you.

A bowel blockage can cause vomiting, cramping pain and inability to pass stool or gas, and it needs urgent medical attention. It can be relieved with bypass surgery, a stoma or a stent placed through a scope.³⁵ A stent is a mesh tube that holds the bowel open and usually means a shorter recovery than surgery. Bypass or a stoma is chosen when a stent isn’t suitable, depending on where the blockage is and how well you are.³⁶